Calidi Biotherapeutics, Inc. Grants Receivable, Current
Calidi Biotherapeutics, Inc. (CLDI) had Grants Receivable, Current of $0 as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Notes › Nontrade Receivables
us-gaap:GrantsReceivableCurrent · last filed 2026-05-14
- 2026-03-31: Grants Receivable, Current $0.00.
- 2025-12-31: Grants Receivable, Current $50.00B.
- 2025-06-30: Grants Receivable, Current $50.00K.
- 2025-03-31: Grants Receivable, Current $50.00B; Grants Receivable, Current as first filed $50.00K.
| Period end | Grants Receivable, Current | Grants Receivable, Current as first filed |
|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $50.00B 10-K · filed 2026-03-27 | |
| 2025-06-30 | $50.00K 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $50.00B 10-Q · filed 2026-05-14 | $50.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $200.00K 10-K · filed 2026-03-27 | |
| 2024-06-30 | $200.00K 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $2.90M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |